Navigating the Immunotherapy Maze
Today, the global immunotherapy drugs market is valued at €139B ($163B) and is estimated to…
11/11/2020 - 2 minutes
CAR-T
ADVERTISEMENT
Do you want to remove this advert? Become a member!
Do Natural Killer Cells Hold the Key to Treating Blood Cancers?
Novel immunotherapies, like T cell therapy, may have shown recent successes but they also come…
28/10/2020 - 7 minutes
From Big Pharma to Startup CEO: Lessons from Kymriah Developer Gaurav Shah
Novartis’ Kymriah, one of the first CAR T-cell therapies to be approved to treat blood…
28/09/2020 - 9 minutes
T-Cell Therapy Firm Wins Massive €93M Series A to Treat Solid Tumors
The Dutch startup Neogene Therapeutics has become the second T-cell therapy developer to raise a…
14/09/2020 - 3 minutes
How European Startups Have Advanced Cancer T-Cell Therapy in 2020
With the help of a huge €66M Series A round last week, the German startup…
11/08/2020 - 8 minutes
Sponsored
by Anemocyte
How Can We Tackle the Bottleneck in Plasmid Production for Gene Therapies?
The cell and gene therapy sector is booming. At the end of 2019, there were…
03/02/2020 - 5 minutes
T-Cell Discovery Could Herald Universal Cancer Immunotherapy
An international research team has found a new type of T-cell that could lead to…
21/01/2020 - 3 minutes
Adaptimmune to Take Off-The-Shelf CAR-T to Phase I with Astellas
The UK biotech Adaptimmune Therapeutics has inked a deal worth up to €806M with Japanese…
15/01/2020 - 2 minutes
BioNTech’s RNA-Boosted CAR T-Cell Therapy Shrinks Tumors in Mice
A CAR T-cell therapy amplified by RNA technology, developed by BioNTech, has shown preclinical potential…
06/01/2020 - 2 minutes
European Biotech’s Top News in 2019
With the year coming to a close, it’s time to review the most important biotech…
30/12/2019 - 10 minutes
Autolus Reveals Early Clinical Data of Next-Gen CAR-T Therapy
London-based Autolus has shown its next-generation CAR T-cell therapy does not induce some of the…
09/12/2019 - 4 minutes
Cellectis’ Off-the-Shelf CAR T-Cell Therapy Shows Solid Tumor Potential
An off-the-shelf, gene edited CAR T-cell therapy, developed by the French biotech Cellectis, could be…
14/11/2019 - 2 minutes
